The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment.
Obstructive sleep apnea syndrome (OSAS) is common in active acromegaly and negatively influences quality of life, morbidity and mortality. This prospective study with three predetermined timepoints and a standardized treatment protocol investigates changes in sleep parameters during the first 2.5 years of acromegaly treatment. Before initiation of acromegaly treatment (medical pretreatment followed by surgery), polysomnography (PSG) was performed in twenty-seven consecutive patients with treatment-naive acromegaly. PSG was repeated after 1 year (N=24) and 2.5 years (N=23), and anthropometric and biochemical parameters were obtained. At baseline, 74.1% of the patients was diagnosed with OSAS. The Respiratory Disturbance Index (RDI; P 0.001), Oxygen Desaturation Index (ODI; P 0.001), lowest oxygen saturation (LSaO2; P 0.007) and the Epworth Sleepiness Scale (ESS; P<0.001) improved significantly during treatment, with the greatest improvement in the first year. After 2.5 years of treatment, all patients had controlled acromegaly. Of the 16 patients with repeated PSGs and OSAS at baseline, 11 (68.8%) were cured of OSAS. Changes in RDI, ODI, LSaO2, and ESS correlated with IGF-1 levels. OSAS has a high prevalence in active acromegaly. There is a substantial decrease in prevalence and severity of OSAS following acromegaly treatment with the largest improvement during the first year. Most surgically and biochemically controlled patients recovered from OSAS. Therefore, a PSG is advised after diagnosis of acromegaly. When OSAS is present, it should be treated and PSGs should be repeated during acromegaly treatment.